Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer

por Csizmarik, Anita, Keresztes, Dávid, Nagy, Nikolett, Bracht, Thilo, Sitek, Barbara, Witzke, Kathrin, Puhr, Martin, Tornyi, Ilona, Lázár, József, Takács, László, Kramer, Gero, Sevcenco, Sabina, Maj‐Hes, Agnieszka, Jurányi, Zsolt, Hadaschik, Boris, Nyirády, Péter, Szarvas, Tibor
Publicado 2022

Plasma Proteomics Enable Differentiation of Lung Adenocarcinoma from Chronic Obstructive Pulmonary Disease (COPD)

por Bracht, Thilo, Kleefisch, Daniel, Schork, Karin, Witzke, Kathrin E., Chen, Weiqiang, Bayer, Malte, Hovanec, Jan, Johnen, Georg, Meier, Swetlana, Ko, Yon-Dschun, Behrens, Thomas, Brüning, Thomas, Fassunke, Jana, Buettner, Reinhard, Uszkoreit, Julian, Adamzik, Michael, Eisenacher, Martin, Sitek, Barbara
Publicado 2022

Comparative proteome analysis identified CD44 as a possible serum marker for docetaxel resistance in castration‐resistant prostate cancer

por Keresztes, Dávid, Csizmarik, Anita, Nagy, Nikolett, Módos, Orsolya, Fazekas, Tamás, Bracht, Thilo, Sitek, Barbara, Witzke, Kathrin, Puhr, Martin, Sevcenco, Sabina, Kramer, Gero, Shariat, Shahrokh, Küronya, Zsófia, Takács, László, Tornyi, Ilona, Lázár, József, Hadaschik, Boris, Lászik, András, Szűcs, Miklós, Nyirády, Péter, Szarvas, Tibor
Publicado 2021